American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System’s Breakthrough Results in Ventilator Weaning
International multi-center trial demonstrates AeroPace strengthens the diaphragm by 50%, weans more patients from ventilation, and reduces ventilator time by 3 days in patients difficult to wean from mechanical ventilation EXTON, PA, June 12, 2025 – Lungpacer Medical, Inc., a pioneering medical device company focused on neurostimulation therapies for critical care patients, today announced the […]
Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients
Exton, PA – April 28, 2025 – This spring, Lungpacer Medical clinical experts and device innovators will be featured presenters at top industry events. Speakers will demonstrate how novel interventional therapies can free critically ill patients from mechanical ventilation and may help improve lung, heart, and brain health in ventilated patients. ISHLT 2025, Boston, April […]
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
Company Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience Exton, PA – March 24, 2025 – Lungpacer Medical today announced the appointment of Kevin Kearney as chief commercial officer (CCO). Kearney brings over 20 years of commercial leadership, business development, and strategic sales operations experience in the medical device and healthcare […]
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
Exton, PA – March 10, 2025 – Lungpacer Medical, a leading neurostimulation company committed to advancing therapies that assist patients in overcoming the negative effects of mechanical ventilation (MV), is excited to announce approval of an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) for the STARI (STimulation to Activate RespIration) […]
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
Exton, PA – February 20, 2025 – Lungpacer Medical, a neurostimulation company dedicated to developing innovative interventional therapies to free patients from mechanical ventilation (MV) and preserve or improve diaphragm, lung, heart, and brain health, shared the results of the STIMULUS trial, a phase 1 clinical study undertaken in collaboration with Toronto General Hospital. The […]
Lungpacer Medical Announces Premarket Approval for AeroPace® System
Exton, PA – December 5, 2024 – Lungpacer Medical, a neurostimulation company dedicated to developing innovative interventional therapies to free patients from mechanical ventilation (MV) and improve diaphragm, lung, heart, and brain health, today announced premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Company’s flagship AeroPace® System. Lungpacer Medical’s AeroPace […]
September 2024 | Lungpacer Medical Announces PMA Submission for AeroPace® System
AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy designed for quicker liberation from mechanical ventilation FOR IMMEDIATE RELEASE Exton, PA – September 4, 2024 – Lungpacer Medical, a neurostimulation company developing interventional therapies to free patients from mechanical ventilation (MV) and improve diaphragm, lung, heart, and brain health, today announced that the Company’s […]
Lungpacer presents at the 2022 Pleural Pressure Working Group (PLUG) meeting
The Pleural Pressure Working Group (PLUG) is an international network of physicians and investigators working on advanced monitoring of mechanical ventilation and respiratory failure. Our goal is to promote research and use of advanced monitoring, discuss study results, and provide educational tools. PLUG working group is open to anybody interested in this topic and is […]
Lungpacer presents at Society of Critical Care Medicine (SCCM) virtual conference
Lungpacer presents at 2022 International Symposium on Intensive Care and Emergency Medicine (ISICEM) conference in Brussels
